Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca


Journal

BMB reports
ISSN: 1976-670X
Titre abrégé: BMB Rep
Pays: Korea (South)
ID NLM: 101465334

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 12 04 2021
pubmed: 4 6 2021
medline: 4 2 2022
entrez: 3 6 2021
Statut: ppublish

Résumé

Although arginase primarily participates in the last reaction of the urea cycle, we have previously demonstrated that arginase II is an important cytosolic calcium regulator through spermine production in a p32-dependent manner. Here, we demonstrated that rhaponticin (RPT) is a novel medicinal-plant arginase inhibitor and investigated its mechanism of action on Ca

Identifiants

pubmed: 34078530
pii: 5346
pmc: PMC8560459

Substances chimiques

Inositol 1,4,5-Trisphosphate Receptors 0
Itpr1 protein, mouse 0
Mitochondrial Proteins 0
Reactive Oxygen Species 0
Stilbenes 0
Nitric Oxide 31C4KY9ESH
Arginine 94ZLA3W45F
Nitric Oxide Synthase Type III EC 1.14.13.39
Nos3 protein, mouse EC 1.14.13.39
Arginase EC 3.5.3.1
rhapontin K691M2Z08V
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

516-521

Références

Hypertension. 2004 Dec;44(6):935-43
pubmed: 15492130
Am J Physiol Endocrinol Metab. 2001 Jan;280(1):E75-82
pubmed: 11120661
J Exp Biol. 2003 Jun;206(Pt 12):2083-7
pubmed: 12756290
Circ Res. 2008 Apr 25;102(8):923-32
pubmed: 18309100
Int Immunopharmacol. 2017 Jan;42:185-194
pubmed: 27930969
J Biol Chem. 1997 Nov 21;272(47):29769-77
pubmed: 9368047
Planta Med. 2009 Apr;75(5):472-7
pubmed: 19235684
Cardiovasc Res. 2010 Jan 1;85(1):147-54
pubmed: 19726439
J Am Heart Assoc. 2018 Sep 18;7(18):e009579
pubmed: 30371203
Circ Res. 2014 Aug 1;115(4):450-9
pubmed: 24903103
Bioorg Med Chem. 2004 Sep 15;12(18):4871-6
pubmed: 15336266
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4202-8
pubmed: 11259671
Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):488-94
pubmed: 19164802
Am J Physiol Regul Integr Comp Physiol. 2005 Apr;288(4):R1057-62
pubmed: 15591155
J Pharmacol Exp Ther. 2006 Sep;318(3):1368-74
pubmed: 16801455
Int Immunopharmacol. 2017 Jun;47:38-46
pubmed: 28364627
Cells. 2020 Feb 08;9(2):
pubmed: 32046324
FASEB J. 2003 Dec;17(15):2328-30
pubmed: 14563685
Arch Pharm Res. 1999 Aug;22(4):401-3
pubmed: 10489881
Circ Res. 2001 Jun 8;88(11):E68-75
pubmed: 11397791
Circulation. 2003 Oct 21;108(16):2000-6
pubmed: 14517171

Auteurs

Bon-Hyeock Koo (BH)

Department of Biological Sciences, Kangwon National University, Chuncheon 24341, Korea.

Jonghoon Lee (J)

Department of Anesthesiology and Pain Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.

Younghyun Jin (Y)

Department of Anesthesiology and Pain Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.

Hyun Kyo Lim (HK)

Department of Anesthesiology and Pain Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.

Sungwoo Ryoo (S)

Department of Biological Sciences, Kangwon National University, Chuncheon 24341, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH